OncoZenge AB's total assets for Q3 2025 were kr19.84M, an increase of 29.95% from the previous quarter. DE:8LY total liabilities were kr10.53M for the fiscal quarter, a 331.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.